MEDANTAGlobal Health Limited
Convert to ideaHealthcare · Healthcare Facilities
The verdict combines business quality, price and timing. Sign in free to see it.
Sign in freeUp 2.3 this quarter.
Momentum from moving averages, Supertrend and RSI.
1 forensic issue found. Sign in to see which.
Valuation Metrics
Q2 FY2027Intrinsic value, Graham number and DCF against today's price
1 found · risk elevated
Quality, growth, balance sheet and earnings quality behind the score
ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.
Financial Metrics
Comparing Q2 FY2027 vs Q2 FY2026
| Quarter | Revenue | Net Profit | OPM | NPM | EPS | Int. Cover |
|---|---|---|---|---|---|---|
| Q2 FY2027 | ₹1469 Cr | ₹219 Cr | 20.37% | 14.92% | ₹8.21 | 11.5x |
| Q1 FY2027 | ₹1304 Cr | ₹157 Cr | 16.70% | 12.06% | ₹5.91 | 9.0x |
| Q4 FY2026 | ₹1159 Cr | ₹142 Cr | 15.29% | 12.22% | ₹5.36 | 8.0x |
| Q3 FY2026 | ₹1121 Cr | ₹95 Cr | 13.92% | 8.48% | ₹3.54 | 6.6x |
| Q2 FY2026 | ₹1099 Cr | ₹158 Cr | 16.49% | 14.41% | ₹5.89 | 12.7x |
| Q1 FY2026 | ₹1031 Cr | ₹159 Cr | 17.64% | 15.42% | ₹5.92 | 16.1x |
Momentum score, 1-year chart, moving averages, support and resistance.
Turnaround stage, and how each measure moved over 3 years against the company's own range.
Order wins, capex, pledges, rating actions and every material filing.
Management guidance, Q&A highlights and whether they delivered what they said.
The earnings call read across investor dimensions.
Promoter, FII and mutual fund holding, and what changed this quarter.
Similar-size peers in Healthcare Facilities
Compare with peers →Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, and dietetics and nutrition, as well as plastic, aesthetic, and reconstructive surgery. It also provides second opinion, lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, and e-ICU services, and health plans checkup. In addition, the company is involved in trading of pharmacy and other medical consumables; and medical and healthcare education activities. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in Gurugram, India.
Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.